Patents by Inventor Valter Domenico Croci

Valter Domenico Croci has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8518930
    Abstract: The present invention provides a therapeutic combination comprising (a) a compound of formula (I) as set forth in the specification and (b) one or more antineoplastic agents selected from the group consisting of alkylating or alkylating-like agents, antimetabolite agents and topoisomerase I inhibitors, wherein the active ingredients are present in each case in free form or in the form of a pharmaceutically acceptable salt or any hydrate thereof.
    Type: Grant
    Filed: July 29, 2009
    Date of Patent: August 27, 2013
    Assignee: Nerviano Medical Sciences S.r.l.
    Inventors: Marina Ciomei, Aurelio Marsiglio, Valter Domenico Croci, Enrico Pesenti
  • Publication number: 20120114641
    Abstract: The present invention provides a combination comprising (a) a compound of formula (I) and (b) one or more antineoplastic agents selected from the group consisting of an antimetabolite agent, analkylating or alkylating-like agent, an intercalating agent, a topoisomerase I or II inhibitor, an antimitotic agent, a kinase inhibitor, a proteasome inhibitor and an antibody inhibiting a growth factor or its receptor, wherein active ingredients of the combination are present in each case in free form or in the form of a pharmaceutically acceptable salt or any hydrate or solvate thereof, useful in the treatment of tumors.
    Type: Application
    Filed: May 21, 2010
    Publication date: May 10, 2012
    Applicant: NERVIANO MEDICAL SCIENCES S.R.L.
    Inventors: Barbara Valsasina, Italo Beria, Antonella Ciavolella, Dario Ballinari, Enrico Pesenti, Valter Domenico Croci, Mara Emanuela Casnaghi, Alessandro Luciano Croci, Juergen Moll
  • Publication number: 20110312909
    Abstract: The present invention provides a therapeutic combination comprising (a) a compound of formula (I) as set forth in the specification and (b) one or more antineoplastic agents selected from the group consisting of alkylating or alkylating-like agents, antimetabolite agents and topoisomerase I inhibitors, wherein the active ingredients are present in each case in free form or in the form of a pharmaceutically acceptable salt or any hydrate thereof.
    Type: Application
    Filed: July 29, 2009
    Publication date: December 22, 2011
    Applicant: Nerviano Medical Sciences S.r.l.
    Inventors: Marina Ciomei, Aurelio Marsiglio, Valter Domenico Croci, Enrico Pesenti